Accessibility Menu
Eurofins Scientific Se logo

Eurofins Scientific Se(OTC) ERFSF

Market Cap$14.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)+429%
5 Year-36%
1 Year+8%
1 Month+5%
$80.75
-2.10%
-1.73Today
Eurofins Scientific Se last closing stock price
MetricPriceDate
Last closeUSD 82.482026-08-13
Eurofins Scientific Se stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.59%USD 81.192026-08-06
1 month+4.62%USD 78.832026-07-14
3 month+24.42%USD 66.292026-05-15
Year to date+13.88%USD 72.432025-12-31
1 year+8.42%USD 76.072025-08-13
3 year+33.27%USD 61.892023-08-14
5 year-35.84%USD 128.562021-08-13
Since inception+429.13%USD 15.592004-03-25

Eurofins Scientific Se Financials at a Glance

Market Cap

$14.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€14.52B

Net Income (TTM)

€962.16M

EPS (TTM)

$3.36

P/E Ratio

23.54

Dividend

$0.84

Beta (Volatility)

0.52 (Low)

Price

$80.75

Volume

2,097

Open

$82.02

Previous Close

$82.48

Daily Range

$80.18 - $82.87

52-Week Range

$64.95 - $86.20

Estimated Earnings Date

Mar 2, 2027

ERFSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eurofins Scientific Se

Eurofins Scientific SE is a global leader in analytical testing and laboratory solutions, offering a wide range of services across various sectors. Established in 1987, the company operates approximately 900 laboratories in 54 countries, utilizing around 200,000 analytical techniques to ensure product safety, compliance, and quality.

Products and Services
  • Comprehensive testing for food, pharmaceuticals, and environmental samples
  • Regulatory compliance and certification services across multiple industries
  • Specialized solutions in biopharma, clinical diagnostics, and forensic science
Growth Outlook
  • Revenue of €3.70 billion in Q2 2026, reflecting strong demand
  • Net income of €301.5 million in Q2 2026, showcasing profitability
  • Consistent expansion in emerging markets and new service offerings
Financial Highlights
  • Trailing twelve months (TTM) revenue of €14.5 billion, indicating robust growth
  • Net profit margin of 7.18% TTM, demonstrating effective cost management
  • Dividend yield of 1.08% TTM, providing a return to shareholders
Eurofins Scientific SE stands out in the medical diagnostics and research industry, driven by its commitment to quality and innovation. The company's diverse portfolio addresses critical needs in food safety, environmental testing, and biopharmaceuticals, positioning it well for future growth. Recent financial performance highlights a strong revenue trajectory and profitability, making it an attractive option for investors seeking exposure to the healthcare sector. With ongoing expansion and a focus on emerging markets, Eurofins is poised to capitalize on increasing global demand for analytical testing services.
AI Generated • Jul 25, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

65,694

CEO

Gilles G. Martin, PhD

Website

www.eurofins.com

Headquarters

Luxembourg City, LU 1526, LU

ERFSF Financials

Key Financial Metrics (TTM)

Gross Margin

11.97%

Operating Margin

11.97%

Net Income Margin

7.18%

Return on Equity

14.81%

Return on Capital

10.26%

Return on Assets

4.77%

Earnings Yield

4.25%

Dividend Yield

1.02%

Payout Ratio

24.57%

Stock Overview

Market Cap

$14.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

173.60M

Volume

2.10K

Avg. Volume

3.27K

Financials (TTM)

Gross Profit

€5.65B

Operating Income

€2.03B

EBITDA

€2.94B

Operating Cash Flow

€2.68B

Capital Expenditure

-€1.26B

Free Cash Flow

€1.42B

Cash & ST Invst.

€617.07M

Total Debt

€5.46B

Eurofins Scientific Se Performance Analysis

Eurofins Scientific Se annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 7,054,244,711-11.2%
20232023-12-31EUR 7,043,035,707-0.2%
20242024-12-31EUR 7,518,832,4476.8%
20252025-12-31EUR 8,234,217,5859.5%
Eurofins Scientific Se sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-313.3%
Q22025-06-302.3%
Q42025-12-312.0%
Q22026-06-300.3%
Eurofins Scientific Se annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 3.22-30.1%
20232023-12-31EUR 1.69-47.4%
20242024-12-31EUR 2.2633.4%
20252025-12-31EUR 2.8727.1%
Eurofins Scientific Se sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-319.0%
Q22025-06-306.4%
Q42025-12-316.0%
Q22026-06-3032.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€3.70B

+8.1%

Gross Profit

€498.25M

-34.1%

Gross Margin

13.48%

N/A

Market Cap

$14.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$217.96K

N/A

Employees

65,694

N/A

Net Income

€301.55M

+36.6%

EBITDA

€795.81M

+5.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€617.07M

-9.4%

Total Debt

€5.46B

+54.2%

Accounts Receivable

€1.55B

+9.5%

Inventory

€144.78M

+1.7%

Long Term Debt

€4.69B

+39.1%

Short Term Debt

€770.84M

+351.6%

Return on Assets

4.77%

N/A

Return on Invested Capital

10.26%

N/A

Free Cash Flow

€383.43M

+22.6%

Operating Cash Flow

€574.14M

+8.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FSPKFFisher & Paykel Healthcare Corporation Limited
$24.55+6.93%
CSPCYCSPC Pharmaceutical Group Limited
$4.40+0.00%
CHJTFCSPC Pharmaceutical Group Limited
$1.07+0.00%
BIOVFSwedish Orphan Biovitrum AB (publ)
$48.21+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.36+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.61-0.00%
INTCIntel
$102.95-0.02%
ONDSOndas
$9.47+0.06%

Questions About ERFSF

What is the current price of Eurofins Scientific Se?

Eurofins Scientific Se is trading at $80.75 per share.

What is the 52-week range for Eurofins Scientific Se?

Over the past 52 weeks, Eurofins Scientific Se has traded between $64.95 and $86.20.

How much debt does Eurofins Scientific Se have?

As of the most recent reporting period, Eurofins Scientific Se reported total debt of €6.38B.

How much cash does Eurofins Scientific Se have on hand?

Eurofins Scientific Se reported €929.22M in cash and cash equivalents in its most recent financial results.

What is Eurofins Scientific Se’s dividend yield?

Eurofins Scientific Se currently has a dividend yield of 1.02%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services